MedPath

ICAHN School of Medicine At Mount Sinai

ICAHN School of Medicine At Mount Sinai logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1963-01-01
Employees
5K
Market Cap
-
Website
http://www.mssm.edu

Impact of Medicaid Health Home on Patients With Diabetes in New York City

Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2016-03-18
Last Posted Date
2022-10-19
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
132
Registration Number
NCT02713321
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Mechanisms Underlying Predictors of Success From Obesity Surgery

Phase 2
Withdrawn
Conditions
Obesity
Interventions
Drug: Exendin 9-39 and Sitagliptin
Drug: Placebo
First Posted Date
2016-03-03
Last Posted Date
2022-11-15
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Registration Number
NCT02697253
Locations
🇺🇸

Mount Sinai - Morningside, New York, New York, United States

Large Scale Cerebral Oximetry During Sinus Endoscopy

Completed
Conditions
Endoscopic Sinus Surgery
Chronic Rhinosinusitis
First Posted Date
2016-02-26
Last Posted Date
2017-08-10
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
100
Registration Number
NCT02692794
Locations
🇺🇸

Icahn School of Medicine, New York, New York, United States

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Not Applicable
Completed
Conditions
Alopecia Areata
Interventions
Drug: Placebo
Drug: Apremilast
First Posted Date
2016-02-17
Last Posted Date
2023-11-07
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
30
Registration Number
NCT02684123
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Not Applicable
Completed
Conditions
Mild Tricuspid Regurgitation
Tricuspid Regurgitation
Moderate Tricuspid Regurgitation
Interventions
Procedure: TV Annuloplasty
Procedure: MVS
First Posted Date
2016-02-05
Last Posted Date
2024-06-18
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
401
Registration Number
NCT02675244
Locations
🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

Ohio State University, Columbus, Ohio, United States

🇺🇸

Mission Hospital, Asheville, North Carolina, United States

and more 37 locations

Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence

Not Applicable
Completed
Conditions
Breast Neoplasms
Musculoskeletal Pain
Interventions
Behavioral: Hypnosis
Behavioral: Attention Control
First Posted Date
2016-01-18
Last Posted Date
2021-06-22
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
191
Registration Number
NCT02657993
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Optimizing Postoperative Cognition the Elderly

Completed
Conditions
POCD
Postoperative Cognitive Dysfunction
Interventions
Procedure: Processed EEG
First Posted Date
2016-01-08
Last Posted Date
2020-03-23
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
178
Registration Number
NCT02650687
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

Phase 4
Terminated
Conditions
Gastric Bypass
Endoscopy
Obesity
Bariatrics
Sleep Apnea Syndromes
Interventions
Drug: Ketofol
Drug: Saline
Drug: Propofol
First Posted Date
2015-12-31
Last Posted Date
2020-02-11
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
22
Registration Number
NCT02643979
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected Adults

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: HEP Course
Behavioral: MBSR Course
First Posted Date
2015-12-10
Last Posted Date
2022-05-09
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
84
Registration Number
NCT02626949
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)

Phase 2
Completed
Conditions
Post-operative Excessive Scarring
Interventions
Drug: Botulinum Toxin
Drug: Saline
First Posted Date
2015-12-08
Last Posted Date
2020-12-08
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
42
Registration Number
NCT02623829
Locations
🇺🇸

Icahn School of Medicine at Mount Sinia, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath